Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?
Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom? Zacks Investment Research
Covered in this story
What has happened since
- Abbott Laboratories is down 5.6% since this was published, 73 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Abbott Laboratories
- Rothschild & Co Redburn: $97.5 → $127 by Oct 2027 via Investing.com
- TD Cowen: $117 → $135 by Aug 2027 · Buy via Investing.com India
- UBS: $107 → $125 by Jul 2027 via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ABT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Abbott Laboratories →Also covered by 1 other outlet
Dalsna Finance is currently tracking 49 stories mentioning Abbott Laboratories, the earliest published 23 May 2026.
Summary aggregated from Zacks Investment Research's public RSS feed. The full reporting belongs to Zacks Investment Research — please read it on their site.